Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2019-11-25 Sale | 2019-11-27 5:01 pm | Neon Therapeutics Inc. | NTGN | GAYNOR RICHARD President of R&D | 65,322 | $1.307 | $85,373 | 156,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-29 Tax Withholding | 2024-07-01 4:55 pm | N/A N/A | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 1,465 | $24.1 | 24,995 (Direct) | View |
2024-06-29 Exercise | 2024-07-01 4:55 pm | N/A N/A | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 6,104 | $0 | 24,995 (Direct) | View |
2024-06-18 Option Award | 2024-06-20 5:01 pm | N/A N/A | Zai Lab Ltd | ZLAB | GAYNOR RICHARD Director | 21,253 | $0 | 49,068 (Direct) | View |
2023-11-17 Other | 2024-06-04 4:53 pm | N/A 2030-12-02 | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 230 | $18.45 | 171,648 (Direct) | View |
2023-11-17 Other | 2024-06-04 4:53 pm | 2024-06-29 N/A | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 119 | $0 | 171,648 (Direct) | View |
2023-11-17 Other | 2024-06-04 4:53 pm | 2024-06-29 2033-06-29 | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 254 | $30.72 | 171,648 (Direct) | View |
2024-05-31 Option Award | 2024-06-04 4:53 pm | 2025-05-31 N/A | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 25,505 | $0 | 171,648 (Direct) | View |
2023-11-17 Other | 2024-06-04 4:53 pm | N/A 2031-06-14 | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 313 | $24.24 | 171,648 (Direct) | View |
2023-11-17 Other | 2024-06-04 4:53 pm | N/A 2030-05-20 | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 256 | $16.52 | 171,648 (Direct) | View |
2023-11-17 Other | 2024-06-04 4:53 pm | N/A 2032-07-07 | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 231 | $30.86 | 171,648 (Direct) | View |
2023-11-17 Other | 2024-06-04 4:53 pm | N/A 2029-12-04 | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 1,460 | $20.81 | 171,648 (Direct) | View |
2023-07-07 Exercise | 2023-07-10 8:30 pm | N/A N/A | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 5,957 | $0 | 20,356 (Direct) | View |
2023-07-07 Tax Withholding | 2023-07-10 8:30 pm | N/A N/A | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 1,430 | $29.88 | 20,356 (Direct) | View |
2023-06-29 Option Award | 2023-06-30 4:33 pm | 2024-06-29 2033-06-29 | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 18,717 | $0 | 18,717 (Direct) | View |
2023-06-29 Option Award | 2023-06-30 4:05 pm | N/A N/A | Zai Lab Ltd | ZLAB | GAYNOR RICHARD Director | 18,903 | $26.45 | 27,815 (Direct) | View |
2022-07-07 Option Award | 2022-07-08 4:19 pm | 2023-07-07 N/A | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 17,511 | $0 | 17,511 (Direct) | View |
2022-06-16 Option Award | 2022-06-16 8:43 pm | N/A 2032-06-16 | INFINITY PHARMACEUTICALS INC. | INFI | GAYNOR RICHARD Director | 45,000 | $0 | 45,000 (Direct) | View |
2022-06-14 Exercise | 2022-06-16 4:57 pm | N/A N/A | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 7,585 | $0 | 15,829 (Direct) | View |
2022-06-14 Tax Withholding | 2022-06-16 4:57 pm | N/A N/A | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 695 | $27.19 | 15,829 (Direct) | View |
2021-12-02 Exercise | 2021-12-03 9:24 pm | N/A N/A | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 5,578 | $0 | 8,939 (Direct) | View |
2021-12-02 Tax Withholding | 2021-12-03 9:24 pm | N/A N/A | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 1,339 | $22.11 | 8,939 (Direct) | View |
2021-11-19 Option Award | 2021-11-22 07:40 am | N/A N/A | Zai Lab Ltd | ZLAB | GAYNOR RICHARD Director | 8,912 | $0 | 8,912 (Direct) | View |
2021-06-14 Option Award | 2021-06-16 4:26 pm | 2022-06-14 2031-06-14 | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 23,262 | $0 | 23,262 (Direct) | View |
2021-06-10 Option Award | 2021-06-11 4:15 pm | N/A 2031-06-09 | INFINITY PHARMACEUTICALS INC. | INFI | GAYNOR RICHARD Director | 30,000 | $0 | 30,000 (Direct) | View |
2021-05-20 Exercise | 2021-05-21 4:35 pm | N/A N/A | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 6,104 | $0 | 4,700 (Direct) | View |
2021-05-20 Tax Withholding | 2021-05-21 4:35 pm | N/A N/A | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 1,404 | $21.92 | 4,700 (Direct) | View |
2020-12-02 Option Award | 2020-12-04 4:33 pm | 2021-12-02 2030-12-02 | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 17,087 | $0 | 17,087 (Direct) | View |
2020-05-20 Option Award | 2020-05-22 4:21 pm | 2021-05-20 2030-05-20 | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 18,927 | $0 | 18,927 (Direct) | View |
2020-05-06 Disposition | 2020-05-06 9:06 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | GAYNOR RICHARD President of R&D | 528,788 | $0 | 0 (Direct) | View |
2020-03-16 Option Award | 2020-03-17 4:34 pm | N/A 2030-03-16 | INFINITY PHARMACEUTICALS INC. | INFI | GAYNOR RICHARD Director | 60,000 | $0 | 60,000 (Direct) | View |
2020-02-29 Tax Withholding | 2020-03-02 6:39 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | GAYNOR RICHARD President of R&D | 5,625 | $1.5 | 210,410 (Direct) | View |
2020-02-25 Tax Withholding | 2020-02-27 6:21 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | GAYNOR RICHARD President of R&D | 5,465 | $1.51 | 216,035 (Direct) | View |
2020-01-12 Option Award | 2020-01-13 5:01 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | GAYNOR RICHARD President of R&D | 65,000 | $0 | 221,500 (Direct) | View |
2019-12-04 Option Award | 2019-12-09 4:11 pm | 2020-12-04 2029-12-04 | Alkermes plc. | ALKS | GAYNOR RICHARD Director | 73,000 | $0 | 73,000 (Direct) | View |
2019-11-25 Option Award | 2019-11-25 5:25 pm | N/A N/A | Neon Therapeutics Inc. | NTGN | GAYNOR RICHARD President of R&D | 75,000 | $0 | 221,822 (Direct) | View |